PIK3CA mutations in breast cancer with low HER2 / neu expression
Introduction. Disturbances in the PI3K-dependent (PI3K – phosphoinositide 3‑kinase) cascade are characteristic of all types of breast cancer. In particular, 30–40 % of patients with advanced / metastatic hormone-positive HER2‑negative (HER2 – human epidermal growth factor receptor 2) breast cancer c...
Saved in:
| Main Authors: | I. A. Pavlenko, P. E. Povilaitite, V. Yu. Kaciyaev, N. S. Makarevich, A. V. Petrov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2022-12-01
|
| Series: | Успехи молекулярной онкологии |
| Subjects: | |
| Online Access: | https://umo.abvpress.ru/jour/article/view/480 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictive and prognostic features of early and locally advanced <i>PIK3CA</i>-mutated luminal HER2-negative breast cancer
by: A. I. Stukan, et al.
Published: (2024-01-01) -
Association of PIK3CA somatic mutations with clinicopathological parameters in breast cancer
by: Gizem Teoman, et al.
Published: (2024-12-01) -
The Effect and Treatment of PIK3CA Mutations in Breast Cancer: Current Understanding and Future Directions
by: Young-Bin Cho, et al.
Published: (2025-03-01) -
Mutations of the PIK3CA gene in patients with breast cancer in the Krasnoyarsk region
by: A. V. Zyuzyukina, et al.
Published: (2024-07-01) -
The role of PIK3CA mutations in the development of breast cancer (a literature review)
by: A. O. Pryvalova, et al.
Published: (2020-08-01)